German API specialist PharmaZell and French CDMO Novasep are in exclusive talks about a merger that the companies say would create a leading European platform in the...
French CDMO Novasep has announced plans to upgrade its API manufacturing facility in Mourenx, increasing its flexibility and competitiveness. The company will invest €6.1...
French CDMO Novasep is expanding its manufacturing capabilities for highly potent active pharmaceutical ingredients (HPAPIs) at its Le Mans site. The investment of more...
19.06.2020
- French contract services firm Novasep has signed an agreement with compatriot biopharma Lysogene to develop and manufacture LYS-GM101, the latter’s Adeno-Associated Virus (AAV)rh10...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
29.03.2016
- French firms Novasep and GTP Technology are combining their services and expertise to advance production of monoclonal antibodies (mAbs). The partnership is particularly targeting...
11.05.2015
- Novasep announced two new appointments to its executive committee (COMEX). Pierre-Louis Mikus joins as chief legal officer. Bertrand Waymel is promoted to group human resources...
28.03.2014
- Novasep, a leading supplier of manufacturing solutions to life science industries, today announces its unaudited consolidated results for the period ended December 31, 2013...
